Bruce Power has partnered with Nordion and Xcision to support the use of Cobalt-60 for life-saving breast cancer treatments in Ontario.
James Scongack of Bruce Power says the GammaPod - Stereotactic Radiotherapy System, created by Xcision has potential to shorten the overall length of treatment for breast cancer.
The Pod uses a continuously rotating multi-source Cobalt-60 system to creating thousands of beam angles which converge to create an intense focal spot, delivering the full dose to the target while sparing surrounding healthy tissue like the heart and lungs.
"Radiotherapy programs in Ontario have been at the forefront of advancing the science of breast cancer treatment, and the GammaPod represents the next advancement in improving the health-care experience for patients," says Scongack.
All three companies are members of the Canadian Nuclear Isotope Council (CNIC), which advocates for Canada's continued role in the production of the world's supply of life-saving radioisotopes.